An Insight into Molecular Targets of Breast Cancer Brain Metastasis.

Biomarkers, Tumor / metabolism Brain Neoplasms / metabolism Breast Neoplasms / metabolism Estrogens Female Humans Progesterone Quality of Life Receptor, ErbB-2 / metabolism Receptors, Progesterone / metabolism Triple Negative Breast Neoplasms / genetics
HER2 TNBC brain metastases breast cancer chemokine receptor

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Oct 2022
Historique:
received: 15 08 2022
revised: 27 09 2022
accepted: 28 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Brain metastasis is one of the major reasons of death in breast cancer (BC) patients, significantly affecting the quality of life, physical activity, and interdependence on several individuals. There is no clear evidence in scientific literature that depicts an exact mechanism relating to brain metastasis in BC patients. The tendency to develop breast cancer brain metastases (BCBMs) differs by the BC subtype, varying from almost half with triple-negative breast cancer (TNBC) (HER2

Identifiants

DOI: 10.3390/ijms231911687 PMID: 36232989 PMC: PMC9569595
pubmed: 36232989
pii: ijms231911687
doi: 10.3390/ijms231911687
pmc: PMC9569595
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Estrogens 0
Receptors, Progesterone 0
Progesterone 4G7DS2Q64Y
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : King Abdulaziz University
ID : IFPDP-51-22

Références

Lung Cancer. 2019 Mar;129:35-40
pubmed: 30797489
Nat Med. 2013 Dec;19(12):1584-96
pubmed: 24309662
Breast. 2020 Dec;54:171-178
pubmed: 33120082
J Clin Oncol. 2016 Feb 10;34(5):443-51
pubmed: 26628478
Br J Pharmacol. 2008 Sep;155(2):185-97
pubmed: 18574456
N Engl J Med. 2020 Feb 13;382(7):610-621
pubmed: 31825192
Cancers (Basel). 2021 Mar 03;13(5):
pubmed: 33802424
Nat Rev Dis Primers. 2019 Sep 23;5(1):66
pubmed: 31548545
Cancer Cell. 2004 Sep;6(3):251-61
pubmed: 15380516
Breast Cancer. 2016 Sep;23(5):732-9
pubmed: 26267412
Cancer. 2016 Jul 1;122(13):2091-100
pubmed: 27088755
J Exp Clin Cancer Res. 2011 Apr 15;30:41
pubmed: 21496237
Acta Neuropathol. 2012 Dec;124(6):763-75
pubmed: 23143192
Nat Rev Dis Primers. 2019 Jan 17;5(1):5
pubmed: 30655533
Eur J Pharm Sci. 2017 Dec 15;110:51-61
pubmed: 28115222
Neoplasia. 2011 Mar;13(3):286-98
pubmed: 21390191
Clin Cancer Res. 2014 Sep 1;20(17):4436-41
pubmed: 24879797
Clin Exp Metastasis. 2020 Aug;37(4):465-475
pubmed: 32533389
J Med Chem. 2005 Feb 24;48(4):1107-31
pubmed: 15715478
Curr Med Chem. 2022 Mar 4;29(8):1436-1458
pubmed: 34238140
Transl Cancer Res. 2020 Aug;9(8):5108-5116
pubmed: 35117877
Front Cell Dev Biol. 2020 Apr 21;8:260
pubmed: 32373613
Front Mol Neurosci. 2019 Nov 21;12:282
pubmed: 31824260
Br J Cancer. 1997;76(4):445-50
pubmed: 9275020
Int J Surg Case Rep. 2020;73:75-78
pubmed: 32650258
Breast Cancer Res Treat. 2018 Apr;168(2):357-364
pubmed: 29198055
Curr Med Chem. 2021;28(39):8068-8082
pubmed: 33167824
Br J Cancer. 2021 Jan;124(1):142-155
pubmed: 33250512
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6395-400
pubmed: 24737887
Adv Anat Pathol. 2020 Jan;27(1):27-35
pubmed: 31045583
J Clin Oncol. 2017 Nov 10;35(32):3638-3646
pubmed: 28968163
Neuro Oncol. 2017 Feb 1;19(2):162-174
pubmed: 28391295
Annu Rev Pathol. 2018 Jan 24;13:395-412
pubmed: 29414248
J Clin Oncol. 2016 Jul 20;34(21):2460-7
pubmed: 27138582
Ann Oncol. 2005 Nov;16(11):1846-7
pubmed: 15972278
Breast Cancer Res Treat. 2016 Jun;157(2):307-318
pubmed: 27167986
Front Oncol. 2020 Jun 05;10:739
pubmed: 32582530
Genes Dis. 2017 Feb 10;4(1):1-3
pubmed: 30258901
Nat Rev Clin Oncol. 2019 Aug;16(8):509-520
pubmed: 30733593
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4607-12
pubmed: 9539785
Cancer Treat Rev. 2022 Feb;103:102324
pubmed: 34953200
Curr Med Imaging. 2021;17(1):120-128
pubmed: 32564758
Curr Med Chem. 2021;28(39):8083-8097
pubmed: 34348607
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Gels. 2022 Jul 19;8(7):
pubmed: 35877535
Nat Rev Clin Oncol. 2009 Apr;6(4):229-36
pubmed: 19333229
OA Mol Oncol. 2013 Apr 1;1(1):
pubmed: 25400938
Breast Cancer (Dove Med Press). 2022 Jan 10;14:1-13
pubmed: 35046721
Asian Pac J Cancer Prev. 2014;15(11):4507-11
pubmed: 24969877
Lancet. 2017 Mar 25;389(10075):1195-1205
pubmed: 28215665
J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):81-8
pubmed: 21590373
Oncotarget. 2017 Dec 11;8(69):114393-114413
pubmed: 29371994
Breast Cancer Res Treat. 2017 Apr;162(2):329-342
pubmed: 28132391
Neuro Oncol. 2017 Jan;19(1):i1-i24
pubmed: 28031389
Cancers (Basel). 2021 Feb 17;13(4):
pubmed: 33671376
Int J Cancer. 2020 Oct 1;147(7):1939-1952
pubmed: 32086955
Breast Cancer Res. 2017 May 2;19(1):54
pubmed: 28464908
J Inherit Metab Dis. 2013 May;36(3):437-49
pubmed: 23609350
J Intern Med. 2013 Aug;274(2):113-26
pubmed: 23844915
Adv Sci (Weinh). 2020 Jan 19;7(5):1901866
pubmed: 32154067
Lancet. 2017 Jun 17;389(10087):2415-2429
pubmed: 27939064
N Engl J Med. 1992 Jul 30;327(5):319-28
pubmed: 1620171
Oncol Lett. 2016 Dec;12(6):4869-4876
pubmed: 28105194
J Cereb Blood Flow Metab. 2017 Oct;37(10):3300-3317
pubmed: 28753105
Recent Results Cancer Res. 2018;211:19-44
pubmed: 30069757
Neuron. 2017 Sep 27;96(1):17-42
pubmed: 28957666
Sci Transl Med. 2013 Apr 10;5(180):180ra48
pubmed: 23576814
Front Oncol. 2021 Jun 16;11:681476
pubmed: 34221999
Int J Mol Sci. 2016 Sep 13;17(9):
pubmed: 27649142
J Clin Med. 2013 Nov 22;2(4):264-82
pubmed: 26237148
Mol Ther Oncolytics. 2020 Mar 13;17:118-129
pubmed: 32322668
Breast Cancer Res Treat. 2021 Sep;189(2):411-423
pubmed: 34302589
Curr Cancer Drug Targets. 2010 Dec;10(8):849-57
pubmed: 20718708
PLoS One. 2015 Mar 05;10(3):e0119655
pubmed: 25742314
Front Biosci (Elite Ed). 2016 Jan 01;8(2):245-63
pubmed: 26709660
Mol Cell Biol. 2005 Dec;25(24):11005-18
pubmed: 16314522
Prog Exp Tumor Res. 1984;27:132-53
pubmed: 6091177
Front Oncol. 2018 May 24;8:161
pubmed: 29881714
Neuro Oncol. 2016 May;18(5):716-24
pubmed: 26519739
Clin Cancer Res. 2014 Jan 15;20(2):404-12
pubmed: 24192926
Ann Oncol. 2014 Jun;25(6):1116-21
pubmed: 24685829
Clin Cancer Res. 2013 Mar 15;19(6):1567-76
pubmed: 23349317
Pharmacol Res. 2020 Jun;156:104806
pubmed: 32294525
Development. 2018 Jul 20;145(14):
pubmed: 30030240
Breast. 2018 Oct;41:57-66
pubmed: 30007269
J Pharmacol Exp Ther. 2002 Jun;301(3):838-51
pubmed: 12023511
Breast Cancer Res. 2016 Jan 19;18(1):8
pubmed: 26781299
Cancer. 1996 Oct 15;78(8):1781-8
pubmed: 8859192
Glia. 2018 Nov;66(11):2438-2455
pubmed: 30357946
Clin Exp Metastasis. 2015 Oct;32(7):729-37
pubmed: 26303828
Epilepsia. 2012 Nov;53 Suppl 6:45-52
pubmed: 23134495
Cancer. 2011 Jul 15;117(14):3093-100
pubmed: 21264845
Nat Commun. 2014 Jun 19;5:4196
pubmed: 24943270
Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):947-57
pubmed: 27284682
Cancer. 1996 Jun 1;77(11):2318-24
pubmed: 8635102
Clin Breast Cancer. 2018 Oct;18(5):e781-e787
pubmed: 29678476
Eur J Med Chem. 2019 Dec 1;183:111718
pubmed: 31581005
Cancer Metastasis Rev. 2020 Sep;39(3):711-720
pubmed: 32399646
Nature. 2016 Apr 14;532(7598):195-200
pubmed: 27027288
Trends Immunol. 2015 Oct;36(10):614-624
pubmed: 26431939
Sci Transl Med. 2017 May 24;9(391):
pubmed: 28539475
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Drug Discov Today. 2008 Dec;13(23-24):1099-106
pubmed: 18848640
J Clin Oncol. 2019 Oct 10;37(29):2610-2619
pubmed: 31430226
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):484-490
pubmed: 27876898
Cancer Res. 1987 Aug 15;47(16):4432-43
pubmed: 3607773
Curr Pharm Des. 2016;22(35):5442-5462
pubmed: 27464716
Neurosurgery. 1999 Apr;44(4):732-40; discussion 740-1
pubmed: 10201297
N Engl J Med. 2020 Feb 13;382(7):597-609
pubmed: 31825569
Nat Commun. 2015 Apr 01;6:6716
pubmed: 25828099
Nat Med. 2016 Jul;22(7):723-6
pubmed: 27270588
Future Oncol. 2021 Sep 1;17(26):3415-3423
pubmed: 34263665
J Neurooncol. 2012 Oct;110(1):79-87
pubmed: 22802020
Int J Mol Sci. 2021 Nov 18;22(22):
pubmed: 34830339
Cancers (Basel). 2021 Aug 17;13(16):
pubmed: 34439289
Nat Rev Neurosci. 2010 Feb;11(2):87-99
pubmed: 20087359
J Clin Oncol. 2017 Sep 20;35(27):3105-3112
pubmed: 28498781
Cancer Res. 2007 Oct 1;67(19):9066-76
pubmed: 17909010
Genes Dev. 2018 Apr 1;32(7-8):466-478
pubmed: 29692355
Neuro Oncol. 2018 Jan 22;20(2):184-191
pubmed: 29016900
ACS Nano. 2018 Aug 28;12(8):8723-8732
pubmed: 30107729
Neuro Oncol. 2011 Aug;13(8):806-19
pubmed: 21757446
Cancer Res Treat. 2020 Oct;52(4):1059-1066
pubmed: 32340083
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Clin Med Insights Oncol. 2020 Sep 17;14:1179554920942440
pubmed: 32994701
Lancet Oncol. 2018 Jan;19(1):87-100
pubmed: 29223745
Nat Med. 2018 Jul;24(7):1024-1035
pubmed: 29892069
Ann Oncol. 2018 Mar 1;29(3):687-693
pubmed: 29293889
Nat Commun. 2019 Jun 11;10(1):2541
pubmed: 31186414
Mol Clin Oncol. 2021 Sep;15(3):175
pubmed: 34276994
Am J Pathol. 2012 Oct;181(4):1126-41
pubmed: 22858156
Breast Cancer Res. 2010;12(4):R46
pubmed: 20604919
Cancer. 2020 Jan 15;126(2):271-280
pubmed: 31581314
Oncotarget. 2017 Jan 24;8(4):6155-6168
pubmed: 28008153

Auteurs

Mohammed Kaleem (M)

Department of Pharmacology, Faculty of Pharmacy, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, India.
ORCID: 0000-0003-4681-2031

Mahmood Hassan Dalhat (MH)

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID: 0000-0002-9982-6026

Lubna Azmi (L)

Department of Pharmaceutics and Pharmacokinetics, CSIR-Central Drug Research Institute, Lucknow 226031, India.

Turky Omar Asar (TO)

Department of Biology, College of Science and Arts at Alkamil, University of Jeddah, Jeddah 23218, Saudi Arabia.

Wasim Ahmad (W)

Department of Kuliyate Tib, National Institute of Unani Medicine, Kottigepalya, Bengaluru 560091, India.

Maimonah Alghanmi (M)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Amal Almostadi (A)

King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Torki A Zughaibi (TA)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID: 0000-0002-2855-5134

Shams Tabrez (S)

Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
ORCID: 0000-0003-4550-415X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs du cerveau › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Hormones › Oestrogènes › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Hormones gonadiques › Hormones sexuelles stéroïdiennes › Congénères de la progestérone › Progestérone › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Récepteur ErbB-2 › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Récepteurs cytoplasmiques et nucléaires › Récepteurs à la progestérone › An Insight into Molecular Targets of Breast...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Tumeurs du sein triple-négatives › An Insight into Molecular Targets of Breast...